市場調査レポート

商品コード

1522714

バイオバンキングの世界市場の評価：製品・サービス別、サンプルタイプ別、保管タイプ別、所有者別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Biobanking Market Assessment, By Product and Service, By Sample Type, By Storage Type, By Ownership, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年07月30日
発行: Market Xcel - Markets and Data
ページ情報: 英文 235 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 660,690円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 836,874円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,203,924円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のバイオバンキングの市場規模は、2024年～2031年の予測期間中に7.60％のCAGRで拡大し、2023年の706億9,000万米ドルから2031年には1,270億2,000万米ドルに成長すると予測されています。市場の成長は、バイオバンキングに関連する様々な利点に対する認識の高まり、慢性疾患の症例の増加、バイオバンキングへの投資の増加によって促進されます。

精密医療や遺伝子検査が重視されるようになり、新生児における臍帯血幹細胞保存の人気が高まっていることも、市場の成長を後押ししています。このような成長は、臍帯血から採取される幹細胞に関連する様々な利点についての認識が高まっていることに起因しています。これらの幹細胞は、がん治療を受けている患者の免疫システムを強化するために使用することができ、将来の応用のために凍結保存することができます。

いくつかの慢性疾患や障害の発生率が上昇していることは、世界のバイオバンキング市場の重要な動向の一つです。集団ベースのバイオバンキングの助けを借りて、研究者は、実験室での検査結果、臨床データ、画像データ、アンケートデータと分子データを組み合わせることにより、様々な疾患の開発における外的要因への曝露や個人の遺伝的感受性の役割を調べることができます。さらに、バイオバンキングが提供する生物学的サンプルは、潜在的なバイオマーカーの検証やスクリーニングに役立ちます。例えば、がん患者の腫瘍サンプルを分析することで、研究者は腫瘍の発生に関連するタンパク質発現パターンの変化や遺伝子変異を発見することができます。

当レポートでは、世界のバイオバンキング市場について調査し、市場の概要とともに、製品・サービス別、サンプルタイプ別、保管タイプ別、所有者別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 3. Global Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 4. Global Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 5. Global Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 6. Global Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 7. Global Biobanking Market Share (%), By Application, 2017-2031F
Figure 8. Global Biobanking Market Share (%), By End-user, 2017-2031F
Figure 9. Global Biobanking Market Share (%), By Region, 2017-2031F
Figure 10. North America Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 11. North America Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 12. North America Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 13. North America Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 14. North America Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 15. North America Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 16. North America Biobanking Market Share (%), By Application, 2017-2031F
Figure 17. North America Biobanking Market Share (%), By End-user, 2017-2031F
Figure 18. North America Biobanking Market Share (%), By Country, 2017-2031F
Figure 19. United States Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 20. United States Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 21. United States Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 22. United States Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 23. United States Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 24. United States Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 25. United States Biobanking Market Share (%), By Application, 2017-2031F
Figure 26. United States Biobanking Market Share (%), By End-user, 2017-2031F
Figure 27. Canada Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 28. Canada Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 29. Canada Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 30. Canada Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 31. Canada Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 32. Canada Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 33. Canada Biobanking Market Share (%), By Application, 2017-2031F
Figure 34. Canada Biobanking Market Share (%), By End-user, 2017-2031F
Figure 35. Mexico Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 36. Mexico Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 37. Mexico Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 38. Mexico Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 39. Mexico Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 40. Mexico Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 41. Mexico Biobanking Market Share (%), By Application, 2017-2031F
Figure 42. Mexico Biobanking Market Share (%), By End-user, 2017-2031F
Figure 43. Europe Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 44. Europe Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 45. Europe Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 46. Europe Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 47. Europe Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 48. Europe Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 49. Europe Biobanking Market Share (%), By Application, 2017-2031F
Figure 50. Europe Biobanking Market Share (%), By End-user, 2017-2031F
Figure 51. Europe Biobanking Market Share (%), By Country, 2017-2031F
Figure 52. Germany Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 53. Germany Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 54. Germany Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 55. Germany Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 56. Germany Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 57. Germany Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 58. Germany Biobanking Market Share (%), By Application, 2017-2031F
Figure 59. Germany Biobanking Market Share (%), By End-user, 2017-2031F
Figure 60. France Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 61. France Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 62. France Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 63. France Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 64. France Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 65. France Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 66. France Biobanking Market Share (%), By Application, 2017-2031F
Figure 67. France Biobanking Market Share (%), By End-user, 2017-2031F
Figure 68. Italy Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 69. Italy Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 70. Italy Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 71. Italy Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 72. Italy Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 73. Italy Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 74. Italy Biobanking Market Share (%), By Application, 2017-2031F
Figure 75. Italy Biobanking Market Share (%), By End-user, 2017-2031F
Figure 76. United Kingdom Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 77. United Kingdom Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 78. United Kingdom Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 79. United Kingdom Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 80. United Kingdom Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 81. United Kingdom Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 82. United Kingdom Biobanking Market Share (%), By Application, 2017-2031F
Figure 83. United Kingdom Biobanking Market Share (%), By End-user, 2017-2031F
Figure 84. Russia Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 85. Russia Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 86. Russia Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 87. Russia Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 88. Russia Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 89. Russia Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 90. Russia Biobanking Market Share (%), By Application, 2017-2031F
Figure 91.
Figure 92. Russia Biobanking Market Share (%), By End-user, 2017-2031F
Figure 93. Netherlands Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 94. Netherlands Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 95. Netherlands Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 96. Netherlands Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 97. Netherlands Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 98. Netherlands Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 99. Netherlands Biobanking Market Share (%), By Application, 2017-2031F
Figure 100. Netherlands Biobanking Market Share (%), By End-user, 2017-2031F
Figure 101. Spain Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 102. Spain Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 103. Spain Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 104. Spain Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 105. Spain Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 106. Spain Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 107. Spain Biobanking Market Share (%), By Application, 2017-2031F
Figure 108. Spain Biobanking Market Share (%), By End-user, 2017-2031F
Figure 109. Turkey Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 110. Turkey Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 111. Turkey Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 112. Turkey Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 113. Turkey Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 114. Turkey Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 115. Turkey Biobanking Market Share (%), By Application, 2017-2031F
Figure 116. Turkey Biobanking Market Share (%), By End-user, 2017-2031F
Figure 117. Poland Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 118. Poland Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 119. Poland Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 120. Poland Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 121. Poland Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 122. Poland Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 123. Poland Biobanking Market Share (%), By Application, 2017-2031F
Figure 124. Poland Biobanking Market Share (%), By End-user, 2017-2031F
Figure 125. South America Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 126. South America Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 127. South America Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 128. South America Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 129. South America Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 130. South America Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 131. South America Biobanking Market Share (%), By Application, 2017-2031F
Figure 132. South America Biobanking Market Share (%), By End-user, 2017-2031F
Figure 133. South America Biobanking Market Share (%), By Country, 2017-2031F
Figure 134. Brazil Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 135. Brazil Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 136. Brazil Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 137. Brazil Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 138. Brazil Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 139. Brazil Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 140. Brazil Biobanking Market Share (%), By Application, 2017-2031F
Figure 141. Brazil Biobanking Market Share (%), By End-user, 2017-2031F
Figure 142. Argentina Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 143. Argentina Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 144. Argentina Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 145. Argentina Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 146. Argentina Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 147. Argentina Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 148. Argentina Biobanking Market Share (%), By Application, 2017-2031F
Figure 149. Argentina Biobanking Market Share (%), By End-user, 2017-2031F
Figure 150. Asia-Pacific Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 151. Asia-Pacific Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 152. Asia-Pacific Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 153. Asia-Pacific Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 154. Asia-Pacific Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 155. Asia-Pacific Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 156. Asia-Pacific Biobanking Market Share (%), By Application, 2017-2031F
Figure 157. Asia-Pacific Biobanking Market Share (%), By End-user, 2017-2031F
Figure 158. Asia-Pacific Biobanking Market Share (%), By Country, 2017-2031F
Figure 159. India Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 160. India Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 161. India Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 162. India Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 163. India Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 164. India Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 165. India Biobanking Market Share (%), By Application, 2017-2031F
Figure 166. India Biobanking Market Share (%), By End-user, 2017-2031F
Figure 167. China Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 168. China Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 169. China Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 170. China Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 171. China Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 172. China Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 173. China Biobanking Market Share (%), By Application, 2017-2031F
Figure 174. China Biobanking Market Share (%), By End-user, 2017-2031F
Figure 175. Japan Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 176. Japan Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 177. Japan Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 178. Japan Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 179. Japan Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 180. Japan Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 181. Japan Biobanking Market Share (%), By Application, 2017-2031F
Figure 182. Japan Biobanking Market Share (%), By End-user, 2017-2031F
Figure 183. Australia Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 184. Australia Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 185. Australia Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 186. Australia Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 187. Australia Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 188. Australia Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 189. Australia Biobanking Market Share (%), By Application, 2017-2031F
Figure 190. Australia Biobanking Market Share (%), By End-user, 2017-2031F
Figure 191. Vietnam Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 192. Vietnam Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 193. Vietnam Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 194. Vietnam Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 195. Vietnam Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 196. Vietnam Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 197. Vietnam Biobanking Market Share (%), By Application, 2017-2031F
Figure 198. Vietnam Biobanking Market Share (%), By End-user, 2017-2031F
Figure 199. South Korea Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 200. South Korea Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 201. South Korea Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 202. South Korea Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 203. South Korea Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 204. South Korea Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 205. South Korea Biobanking Market Share (%), By Application, 2017-2031F
Figure 206. South Korea Biobanking Market Share (%), By End-user, 2017-2031F
Figure 207. Indonesia Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 208. Indonesia Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 209. Indonesia Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 210. Indonesia Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 211. Indonesia Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 212. Indonesia Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 213. Indonesia Biobanking Market Share (%), By Application, 2017-2031F
Figure 214. Indonesia Biobanking Market Share (%), By End-user, 2017-2031F
Figure 215. Philippines Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 216. Philippines Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 217. Philippines Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 218. Philippines Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 219. Philippines Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 220. Philippines Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 221. Philippines Biobanking Market Share (%), By Application, 2017-2031F
Figure 222. Philippines Biobanking Market Share (%), By End-user, 2017-2031F
Figure 223. Middle East & Africa Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 224. Middle East & Africa Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 225. Middle East & Africa Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 226. Middle East & Africa Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 227. Middle East & Africa Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 228. Middle East & Africa Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 229. Middle East & Africa Biobanking Market Share (%), By Application, 2017-2031F
Figure 230. Middle East & Africa Biobanking Market Share (%), By End-user, 2017-2031F
Figure 231. Middle East & Africa Biobanking Market Share (%), By Country, 2017-2031F
Figure 232. Saudi Arabia Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 233. Saudi Arabia Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 234. Saudi Arabia Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 235. Saudi Arabia Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 236. Saudi Arabia Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 237. Saudi Arabia Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 238. Saudi Arabia Biobanking Market Share (%), By Application, 2017-2031F
Figure 239. Saudi Arabia Biobanking Market Share (%), By End-user, 2017-2031F
Figure 240. UAE Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 241. UAE Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 242. UAE Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 243. UAE Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 244. UAE Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 245. UAE Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 246. UAE Biobanking Market Share (%), By Application, 2017-2031F
Figure 247. UAE Biobanking Market Share (%), By End-user, 2017-2031F
Figure 248. South Africa Biobanking Market, By Value, In USD Billion, 2017-2031F
Figure 249. South Africa Biobanking Market, By Volume, In Thousand Units, 2017-2031F
Figure 250. South Africa Biobanking Market Share (%), By Product and Service, 2017-2031F
Figure 251. South Africa Biobanking Market Share (%), By Sample Type, 2017-2031F
Figure 252. South Africa Biobanking Market Share (%), By Storage Type, 2017-2031F
Figure 253. South Africa Biobanking Market Share (%), By Ownership, 2017-2031F
Figure 254. South Africa Biobanking Market Share (%), By Application, 2017-2031F
Figure 255. South Africa Biobanking Market Share (%), By End-user, 2017-2031F
Figure 256. By Product and Service Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 257. By Sample Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 258. By Storage Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 259. By Ownership Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 260. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 261. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 262. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11664

Global biobanking market is projected to witness a CAGR of 7.60% during the forecast period 2024-2031, growing from USD 70.69 billion in 2023 to USD 127.02 billion in 2031. The growth of the market is augmented by the growing awareness of various advantages associated with biobanks, rise in cases of chronic diseases, and increasing investments towards biobanks.

The increasing emphasis on precision medicine and genetic testing and the rising popularity of cord blood stem cell preservation in newborns boosts the market's growth. This rise can be attributed to the growing awareness about the various advantages associated with stem cells from cord blood. These stem cells can be used to strengthen the immune system of patients undergoing cancer treatments and can be frozen and stored away for future applications.

The rising incidences of several chronic diseases and disorders are one of the significant global biobanking market trends. With the help of population-based biobanks, researchers are able to examine the role of exposure to external factors and individual genetic susceptibility in the development of various diseases by combining laboratory test results, clinical data, imaging data, and questionnaire data with molecular data. Additionally, the biological samples provided by biobanks can aid in validating and screening potential biomarkers. For instance, by analyzing tumor samples from cancer patients, researchers are able to discover changes in protein expression patterns and gene mutations that are associated with tumor development.

Increasing Prevalence of Chronic Diseases Boosts Market Demand

The rise in the number of cases of various chronic diseases in different regions is propelling the global biobanking market demand. Cardiovascular disorders are one of the leading causes of death. Cardiology research has discovered several genetic markers and proteins that might be responsible for the disorders. Biobanks have played a crucial role in these research activities by providing relevant samples to enhance the understanding of the therapy, prognosis, and diagnosis of cardiovascular disorders. According to the estimates of the US Centers for Disease Control and Prevention, approximately 695,000 individuals died from heart disease in 2021.

Similarly, cancer cases are rising, propelling the market demand as biobanks store samples and other essential data in a planned and systematic manner. This allows for detection, diagnosis, treatment, prevention of cancer, progressing genetic studies, and aiding researchers in identifying potential drug targets. The American Cancer Society estimated that 2,001,140 new cases of cancer and 611,720 deaths related to the disease are expected to occur in 2024 in the United States.

Rising Investments Towards Biobanks Support Market Expansion

The increasing investments in biobanks due to the growing awareness of various advantages is one of the significant factors bolstering the global biobanking market growth. Biobanks play a crucial role in precision medicine and have supported medical advancements, such as anticipation of dementia, similar conditions, and prevention of heart attacks. Biobanking technology has aided healthcare professionals and researchers in developing tests capable of predicting patients' response to immunotherapy. Furthermore, the DNA data collected from biobanks has allowed researchers to determine the correct dosages of anticoagulants, thus boosting investments in biobanks in various regions across the globe. In June 2024, the iCAN national program launched a funding of USD 2.7 million (EUR 2.5 million) for cancer centers biobank projects. The project is expected to expand the molecular profiling of cancer in Finland and aims to identify new targets for treatment. The project, launched within the framework of the Southern Cancer Center and in cooperation between the HUS Helsinki University Hospital and the University of Helsinki, aims to expand to all the FICAN National Cancer Centers in alliance with the regional biobanks.

Europe Expected to Account for Significant Market Share

The growth of the European market is augmented by the strong presence of key market players, expansion of the research and development sector in healthcare, and growing awareness about various advantages associated with biobanks. Biobanking is essential for preserving specimens and plays a crucial role in enhancing the knowledge of healthcare professionals and researchers, allowing them to develop new technologies for treating and detecting diseases. Thus, the market is witnessing significant growth in Europe due to the rising prevalence of various chronic diseases in the region. According to the estimates of the Europa Donna, The European Breast Cancer Coalition, 604,900 incidences of cancer were reported in Europe in 2022. This increase is further propelling the requirement for biobanks in the region as they play a vital role in aiding researchers in studying various mechanisms associated with the development of cancer and their response to treatment, progression, and resistance.

Equipment Segment Anticipated to Hold Significant Market Share

The expansion of the segment is supported by the rising collection of bio-samples and an increasing number of biobanks. Biobanking equipment plays a crucial role in storing, processing, analyzing, and transporting samples and is responsible for catering to the diverse sets of requirements of medical facilities, biobanks, and research institutes. The rising efforts of various medical technology companies towards the development and introduction of advanced solutions is another major factor supporting the segment's expansion. In July 2023, Tecan Group Ltd. introduced a new phase separator to enhance automation in biobanking and liquid biopsy. The phase separator is expected to support advancements across various disease areas, including metabolic diseases, neurodegenerative diseases, oncology, proteomics, genomics, and others.

Future Market Scenario (2024 - 2031F)

The increasing investments in constructing biobanks are expected to boost the market's growth in the forecast years. Various clinical trials for several diseases and increasing utilization of stem cell therapies for treating rare and chronic diseases are other significant factors expected to boost the requirement for biobanking products. The increasing complexity of life science research is another major factor creating the requirement for high-quality specimens, which in turn is augmenting the investments in the construction of biobanks. Additionally, advancements in biomedical research technologies, such as molecular profiling, high-throughput screening, and next-generation sequencing, are propelling the requirement for large-scale sample repositories to support their execution. Thus, due to the rising efforts of researchers to enhance human health and increase their understanding of various diseases, the requirement for biobanking is expected to rise in the coming years.

Key Players Landscape and Outlook

The rising investments by the key players of the market toward the introduction of novel technologies are bolstering the global biobanking market size. In January 2024, Thermo Fisher Scientific Inc. announced the launch of the new Axiom PangenomiX Array, their ethnically diverse and most extensive array that offers genetic coverage in pharmacogenomic research and population-scale disease research studies. At present, the array is the only research solution that combines fixed copy number discovery, whole-genome copy number variant detection, HLA typing, and SNP genotyping in one test. The array has already found application at a leading biobank in the United States for analyzing close to half a million ethnically diverse samples.

Additionally, in May 2024, Hamilton Company announced that four high-capacity BiOS automated storage systems will be installed in the new Manchester Science Park headquarters of the United Kingdom Biobank. The systems are expected to store over 12 million biological samples and have a capacity of an additional 8 million samples.

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Biobanking Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. By Product and Service
- 4.2.1. Equipment
  - 4.2.1.1. Storage Equipment
  - 4.2.1.2. Sample Processing Equipment
  - 4.2.1.3. Sample Analysis Equipment
  - 4.2.1.4. Sample Transport Equipment
- 4.2.2. Consumables
  - 4.2.2.1. Storage Consumables
  - 4.2.2.2. Processing Consumables
  - 4.2.2.3. Analysis Consumables
  - 4.2.2.4. Collection Consumables
- 4.2.3. Services
  - 4.2.3.1. Storage Services
  - 4.2.3.2. Processing Services
  - 4.2.3.3. Transport Services
  - 4.2.3.4. Supply Services
- 4.2.4. Software
4.3. By Sample Type
- 4.3.1. Stem Cells
- 4.3.2. Human Tissues
- 4.3.3. Blood Product
- 4.3.4. Biological Fluids
- 4.3.5. Human Waste Products
- 4.3.6. Nucleic Acids
4.4. By Storage Type
- 4.4.1. Manual Storage
- 4.4.2. Automated Storage
4.5. By Ownership
- 4.5.1. National/Regional Agencies
- 4.5.2. Universities
- 4.5.3. Private Organizations
- 4.5.4. Non-profit Organizations
4.6. By Application
- 4.6.1. Life Science Research
- 4.6.2. Clinical Research
- 4.6.3. Regenerative Medicine
4.7. By End-user
- 4.7.1. Pharmaceutical and Biotechnology Companies
- 4.7.2. CROs and CMOs
- 4.7.3. Academic and Research Institutes
- 4.7.4. Hospitals
4.8. By Region
- 4.8.1. North America
- 4.8.2. South America
- 4.8.3. Europe
- 4.8.4. Asia-Pacific
- 4.8.5. Middle East & Africa
4.9. By Company Market Share (%), 2023

5. Global Biobanking Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
  - 5.1.1.2. By Volume
- 5.1.2. By Product and Service
  - 5.1.2.1. Equipment
    - 5.1.2.1.1. Storage Equipment
    - 5.1.2.1.2. Sample Processing Equipment
    - 5.1.2.1.3. Sample Analysis Equipment
    - 5.1.2.1.4. Sample Transport Equipment
  - 5.1.2.2. Consumables
    - 5.1.2.2.1. Storage Consumables
    - 5.1.2.2.2. Processing Consumables
    - 5.1.2.2.3. Analysis Consumables
    - 5.1.2.2.4. Collection Consumables
  - 5.1.2.3. Services
    - 5.1.2.3.1. Storage Services
    - 5.1.2.3.2. Processing Services
    - 5.1.2.3.3. Transport Services
    - 5.1.2.3.4. Supply Services
  - 5.1.2.4. Software
- 5.1.3. By Sample Type
  - 5.1.3.1. Stem Cells
  - 5.1.3.2. Human Tissues
  - 5.1.3.3. Blood Product
  - 5.1.3.4. Biological Fluids
  - 5.1.3.5. Human Waste Products
  - 5.1.3.6. Nucleic Acids
- 5.1.4. By Storage Type
  - 5.1.4.1. Manual Storage
  - 5.1.4.2. Automated Storage
- 5.1.5. By Ownership
  - 5.1.5.1. National/Regional Agencies
  - 5.1.5.2. Universities
  - 5.1.5.3. Private Organizations
  - 5.1.5.4. Non-profit Organizations
- 5.1.6. By Application
  - 5.1.6.1. Life Science Research
  - 5.1.6.2. Clinical Research
  - 5.1.6.3. Regenerative Medicine
- 5.1.7. By End-user
  - 5.1.7.1. Pharmaceutical and Biotechnology Companies
  - 5.1.7.2. CROs and CMOs
  - 5.1.7.3. Academic and Research Institutes
  - 5.1.7.4. Hospitals
- 5.1.8. United States*
  - 5.1.8.1. Market Size & Forecast
    - 5.1.8.1.1. By Value
    - 5.1.8.1.2. By Volume
  - 5.1.8.2. By Product and Service
    - 5.1.8.2.1. Equipment
      - 5.1.8.2.1.1. Storage Equipment
      - 5.1.8.2.1.2. Sample Processing Equipment
      - 5.1.8.2.1.3. Sample Analysis Equipment
      - 5.1.8.2.1.4. Sample Transport Equipment
    - 5.1.8.2.2. Consumables
      - 5.1.8.2.2.1. Storage Consumables
      - 5.1.8.2.2.2. Processing Consumables
      - 5.1.8.2.2.3. Analysis Consumables
      - 5.1.8.2.2.4. Collection Consumables
    - 5.1.8.2.3. Services
      - 5.1.8.2.3.1. Storage Services
      - 5.1.8.2.3.2. Processing Services
      - 5.1.8.2.3.3. Transport Services
      - 5.1.8.2.3.4. Supply Services
    - 5.1.8.2.4. Software
  - 5.1.8.3. By Sample Type
    - 5.1.8.3.1. Stem Cells
    - 5.1.8.3.2. Human Tissues
    - 5.1.8.3.3. Blood Product
    - 5.1.8.3.4. Biological Fluids
    - 5.1.8.3.5. Human Waste Products
    - 5.1.8.3.6. Nucleic Acids
  - 5.1.8.4. By Storage Type
    - 5.1.8.4.1. Manual Storage
    - 5.1.8.4.2. Automated Storage
  - 5.1.8.5. By Ownership
    - 5.1.8.5.1. National/Regional Agencies
    - 5.1.8.5.2. Universities
    - 5.1.8.5.3. Private Organizations
    - 5.1.8.5.4. Non-profit Organizations
  - 5.1.8.6. By Application
    - 5.1.8.6.1. Life Science Research
    - 5.1.8.6.2. Clinical Research
    - 5.1.8.6.3. Regenerative Medicine
  - 5.1.8.7. By End-user
    - 5.1.8.7.1. Pharmaceutical and Biotechnology Companies
    - 5.1.8.7.2. CROs and CMOs
    - 5.1.8.7.3. Academic and Research Institutes
    - 5.1.8.7.4. Hospitals
- 5.1.9. Canada
- 5.1.10. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East and Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Product and Service
6.2. By Sample Type
6.3. By Storage Type
6.4. By Ownership
6.5. By Application
6.6. By End-user
6.7. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat from New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Patent Landscape
9.2. Regulatory Approvals
9.3. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Thermo Fisher Scientific Inc.
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products and Services
- 13.1.4. Financials (As Reported)
- 13.1.5. Key Market Focus and Geographical Presence
- 13.1.6. Recent Developments
13.2. Danaher Corporation
13.3. Becton, Dickinson and Company
13.4. Merck & Co., Inc.
13.5. Hamilton Company
13.6. Tecan Group Ltd.
13.7. Azenta US, Inc.
13.8. BioLife Solutions Inc.
13.9. VWR International, LLC
13.10. Biovault Technical

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

バイオバンキングの世界市場の評価：製品・サービス別、サンプルタイプ別、保管タイプ別、所有者別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Biobanking Market Assessment, By Product and Service, By Sample Type, By Storage Type, By Ownership, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のバイオバンキング市場の見通し、2017年～2031年

第5章世界のバイオバンキング市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要参入企業の見通し

第14章戦略的提言

第15章お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Biobanking Market Outlook, 2017-2031F

5. Global Biobanking Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us and Disclaimer

バイオバンキングの世界市場の評価：製品・サービス別、サンプルタイプ別、保管タイプ別、所有者別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Biobanking Market Assessment, By Product and Service, By Sample Type, By Storage Type, By Ownership, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界のバイオバンキング市場の見通し、2017年～2031年

第5章 世界のバイオバンキング市場の見通し、地域別、2017年～2031年

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要参入企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要参入企業の見通し

第14章 戦略的提言

第15章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Biobanking Market Outlook, 2017-2031F

5. Global Biobanking Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us and Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界のバイオバンキング市場の見通し、2017年～2031年

第5章世界のバイオバンキング市場の見通し、地域別、2017年～2031年

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要参入企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要参入企業の見通し

第14章戦略的提言

第15章お問い合わせと免責事項